ArticleCureus2025
Atypical Presentation of Non-small Cell Lung Carcinoma.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The typical presentation of non-small cell lung carcinoma (NSCLC) is hemoptysis, dyspnea, and chest pain. A late cancer diagnosis commonly leads to the patient presenting with metastasis to the bone, liver, adrenal glands, or brain. We present a 58-year-old man who visited the emergency department with a headache for two weeks. A CT scan of the brain revealed a right posterior parietal mass with surrounding vasogenic edema and sulcal effacement as well as a large mass arising from the sella. The patient underwent mass resection, and the pathology results indicated a metastatic adenosquamous carcinoma of the lung. The patient later returned to the emergency department with dyspnea and a cough, and a thorough work-up indicated the patient was suffering from cardiac tamponade secondary to metastasis. The patient underwent a pericardiectomy, pericardial window, and thoracentesis with thoracostomy tube placement. One liter of pericardial fluid was removed, and he was discharged with follow-up for outpatient treatment. Overall, this patient has a poor prognosis due to the presentation of metastases to the brain and pericardium. This case underscores the importance of considering NSCLC in patients with unusual central nervous system presentations and highlights the rare but critical manifestations of pituitary and pericardial metastases. Given the poor prognosis associated with metastatic cardiac tamponade and pituitary involvement, early recognition and symptom management are essential to optimizing patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.